7 Good Reasons for starting early with your Secondary Packaging Strategy for Injectables
Sponsored by: Vetter
- Packaging Strategy
- Volume Scale Up
Date: 14 November
Time: 3PM London/10AM New York
When it comes to clinical phase III, pharmaceutical and biotechnology companies usually focus on the upcoming manufacturing scale-up and on regulatory requirements. At this stage, it is important to plan a secondary packaging strategy.
In this webinar, you will learn why secondary packaging should be integrated at an early stage of your project. Ingo Schraut, Product and Service Manager at Vetter will provide tactical insights on this issue including volume scale-up and the impact of primary packaging on secondary packaging. We will also give you a check list that includes the most important aspects that need to be covered at an early stage of the project.
Our expert will explain what is important in the choice of the correct contract manufacturing partner. CDMOs need to be able to provide optimized solutions for the whole manufacturing process, from clinical development to commercial filling and secondary packaging.
Product- & Service-Manager
For the last six years Ingo Schraut has been working for different companies as international product manager, focusing on building up new business segments that embed complex products into a challenging process landscape, such as OR integration and telemedicine. Since 2018 Ingo is working for Vetter Pharma International as product and service manager. Ingo is part of Vetter’s dedicated secondary packaging team that is constantly looking for opportunities to enhance offered services and streamline processes. This includes for example safety devices for syringes, pens, auto injectors and kit packaging of vials.
Ingo holds a Master of Engineering in Medical Engineering from the University of Applied Sciences, Ulm and a Diploma in Media Technology from the Hochschule der Medien, Stuttgart.
Team Leader, Secondary Packaging, Vetter
Susanne Hall is Team Leader, Secondary Packaging of Vetter Development Service. In this position, she is responsible for overseeing a team of individuals focused on the development and testing of secondary packaging projects, including cartons and kits that meet customers exacting specifications.
Ms. Hall joined Vetter’s Research and Development department in 1993 as Head of Packaging Material Input Control. She has held a variety of positions of increasing responsibility including work on Metal Injection Molding, coordinating working groups, and customer care prior to being named Team Leader of Secondary Packaging in 2008.
Key Learning Objectives
- Why it is important to early plan a secondary packaging strategy
- Impacts on Secondary Packaging
- Important aspects in the choice of CDMO
- Check list including the most important aspects that need to be covered at an early stage of the project
- Head of Secondary Packaging Development
- Head of Drug Product Development
- Sourcing Manager Research Outsourcing
- Head of Research and Development
- Clinical Research Managers
- Manager Strategic Outsourcing